---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-025072"
form_type: "8-K/A"
ticker: "WGRX"
cik: "0002030763"
company_name: "Wellgistics Health, Inc."
filed_at: "2025-11-26T23:59:59+00:00"
generated_at: "2026-05-16T16:40:51.630717+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Wellgistics licenses DataVault AI smart contract IP for PharmacyChain; $2.5M upfront plus royalties

## Summary
- Upfront license fee of $2.5M due by Dec 31, 2025; ongoing 13% royalty on PharmacyChain net profit.
- Minimum annual royalty of $1M from 2028, waived if PharmacyChain net profit under $2M in 2028-2029.
- DataVault receives 90% of any sublicensing revenue Wellgistics generates from the licensed IP.
- Exclusive license for DataVault's smart contract patents in prescription drug distribution; Wellgistics to build PharmacyChain platform.
- Wellgistics expects to integrate with EinsteinRx AI, targeting disruption of PBM rebate system in $634B US drug market.

## SEC filing metadata
- accession: 0001493152-25-025072
- form_type: 8-K/A
- ticker: WGRX
- cik: 0002030763
- company_name: Wellgistics Health, Inc.
- filed_at: 2025-11-26T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2030763/000149315225025072/0001493152-25-025072-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2030763/000149315225025072/form8-ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-025072
- JSON: https://secwatch.observer/filing/0001493152-25-025072.json
- Plain text: https://secwatch.observer/filing/0001493152-25-025072.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.